Evidence map›Paper›PMID 35884520›Full record

ArticleCancers2022

Formulation of a Thermosensitive Imaging Hydrogel for Topical Application and Rapid Visualization of Tumor Margins in the Surgical Cavity.

Ethan Walker, Daan G J Linders, Eric Abenojar, Xinning Wang, Hans Marten Hazelbag, Marieke E Straver, Okker D Bijlstra, Taryn L March, Alexander L Vahrmeijer, Agata Exner and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Ethan WalkerDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0002-5132-8191
Daan G J LindersDepartment of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0003-4524-4175
Eric AbenojarDepartment of Radiology, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0002-2733-4006
Xinning WangDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0001-7729-0534
Hans Marten HazelbagDepartment of Pathology, Haaglanden Medical Center, 2512 VA The Hague, The Netherlands.
Marieke E StraverDepartment of Surgery, Haaglanden Medical Center, 2512 VA The Hague, The Netherlands.
Okker D BijlstraDepartment of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0001-9069-500X
Taryn L MarchDepartment of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Alexander L VahrmeijerDepartment of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Agata ExnerDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0003-3913-7066
Matthew BogyoDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0003-3753-4412
James P BasilionDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0002-8659-3307
Brian StraightAkrotome Imaging Inc., Charlotte, NC 28205, USA.
Case Western Reserve University · USLeiden University Medical Center · NLAkrotome Imaging (United States) · USMedisch Centrum Haaglanden · NLStanford University · US

Funding

Fluorescence-guided resection of breast tumors using a topically-applied molecular probeR01CA246678 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI BASILION, JAMES PETER · 2020 to 2025
$2.8M
NCI NIH HHS R01 CA246678NIH HHS 5R01CA246678-02
6 · The paper itself

Abstract

backgroundTumor-positive surgical margins during primary breast cancer (BCa) surgery are associated with a two-fold increase in the risk of local recurrence when compared with tumor-negative margins. Pathological microscopic evaluation of the samples only assesses about 1/10 of 1% of the entire volume of the removed BCa specimens, leading to margin under-sampling and potential local recurrence in patients with pathologically clean margins, i.e., false negative margins. In the case of tumor-positive margins, patients need to undergo re-excision and/or radiation therapy, resulting in increases in complications, morbidity, and healthcare costs. Development of a simple real-time imaging technique to identify residual BCa in the surgical cavity rapidly and precisely could significantly improve the quality of care.

methodsA small-molecule, fluorescently quenched protease-substrate probe, AKRO-QC-ICG, was tested as part of a thermosensitive imaging gel formulated for topical application and imaging of the BCa surgical cavity.

resultsMore than forty formulations of gel mixtures were investigated to enable easy fluid application and subsequent solidification once applied, preventing dripping and pooling in the surgical cavity. The final formulation was tested using human BCa orthotopic implants in nude and NSG patient-derived xenografts (PDX) mice. This formulation of Pluronic F-127/DMSO/AKRO-QC-ICG imaging gel was found to be a good solvent for the probe, with a desirable thermo-reversible solid-gel transition and mechanical strength for distribution of AKRO-QC-ICG on the surfaces of tissue. It demonstrated excellent ability to detect BCa tissue after 10 min exposure, with a high signal-to-noise ratio both in mouse xenografts and freshly excised human lumpectomy tissue. The in vivo efficacy of the AKRO-QC-ICG imaging gel to detect BCa revealed the levels of sensitivity/specificity = 0.92/1 in 12 nude mice, which was corroborated with the sensitivity/specificity = 0.94/1 in 10 PDX mice.

conclusionsUtilization of Pluronic F-127/DMSO/AKRO-QC-ICG imaging gel for topical application to detect BCa in the surgical cavity during surgery has the potential to reduce re-excisions, with consequent savings in healthcare costs and enhancement in patient quality of life.

Indexed as

human breast canceroptical imagingsurgical cavitytumor margins

Identifiers

PMID35884520
PMCPMC9323389
OpenAlexW4285732512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.